Banner
Here's Where Your Backyard Was 300 Million Years Ago

We may use terms like "grounded" and terra firma to mean stability and consistency but geology...

Convergent Evolution Cheat Sheet Now 120 Million Years Old

One tenet of natural selection is a random walk of genes but nature may be more predictable than...

Synchrotron Could Shed Light On Exotic Dark Photons

There are many hypothetical particles proposed to explain dark matter and one idea to explore how...

The Pain Scale Is Broken But This May Fix It

Chronic pain is reported by over 20 percent of the global population but there is no scientific...

User picture.
News StaffRSS Feed of this column.

News Releases From All Over The World, Right To You... Read More »

Blogroll

The structural components of advanced reactors such as the sodium fast reactor and the traveling wave nuclear reactor must be able to withstand the extreme levels of radioactivity from the fission reaction itself, at temperatures well above 400 Celsius. Standard tests of such components are expensive, require increasingly rare test reactors and test periods that are impractical. In addition, the samples themselves also become radioactive making subsequent studies and examination time consuming and expensive. 

Nonetheless, understanding how these structural components are affected by radiation at the microscopic level is critical to building long-lasting, robust and safe nuclear reactors. 

Where the river meets the sea, there is the potential to harness a significant amount of renewable energy, according to a team of mechanical engineers at MIT who evaluated the method of power generation called pressure retarded osmosis (PRO), in which two streams of different salinity are mixed to produce energy.

A pressure retarded osmosis system of this kind takes in river water and seawater on either side of a semi-permeable membrane. Through osmosis, water from the less-salty stream would cross the membrane to a pre-pressurized saltier side, creating a flow that can be sent through a turbine to recover power.
Changes in the Asian monsoon have affected emissions of methane from the Tibetan Plateau over the last 6,000 years, finds a new paper.

The concentration of methane in the atmosphere has more than doubled over the past century, though it is very short lived compared to carbon dioxide and hasn't been considered much of a factor in climate change. Factors in methane levels include leaks from gas wells, increased rice cultivation and ruminant animals in the dairy and meat industry. It could also be caused partly by climate change feedbacks on natural processes, but that remains the subject of intense investigation. 

Researchers have developed a way to use windows for solar energy - without ruining your view.

The new technology is a solar concentrator, called a transparent luminescent solar concentrator, that is placed over the window and creates solar energy while still allowing people to see through it. The Michigan State University researchers say it can also be used on buildings, cell phones or any other device that has a flat, clear surface.

Attempts to create solar cells with luminescent plastic-like materials is not new but past efforts yielded poor results – the energy production was inefficient and the materials were highly colored.

Earth's magnetic field, a familiar directional indicator over long distances, is routinely probed in applications ranging from geology to archeology, and now it has provided the basis for a technique which could characterize the chemical composition of fluid mixtures in their native environments.

Researchers from the Lawrence Berkeley National Laboratory conducted a proof-of-concept nuclear magnetic resonance experiment in which a mixture of hydrocarbons and water was analyzed using a high-sensitivity magnetometer and a magnetic field comparable to that of the Earth.

Ruxolitinib (trade name: Jakavi) has been approved since August 2012 for the treatment of adults with myelofibrosis.

Myelofibrosis is a rare disease of the bone marrow, in which the bone marrow is replaced by connective tissue. As a consequence of this so-called fibrosis, the bone marrow is no longer able to produce enough blood cells. Sometimes the spleen or the liver takes over some of the blood production.  Then these organs enlarge and can cause abdominal discomfort and pain. The typical symptoms also include feeling of fullness, night sweats and itching. Some patients with myelofibrosis develop leukemia.

Stem cell transplantation is currently the only option to cure myelofibrosis. The drug ruxolitinib aims to relieve the symptoms of myelofibrosis.